You have 9 free searches left this month | for more free features.

Hepatoblastoma

Showing 26 - 50 of 87

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Tumor, Fibrolamellar Carcinoma Trial in Worldwide (drug, other,

Recruiting
  • Childhood Hepatocellular Carcinoma
  • +4 more
  • Birmingham, Alabama
  • +201 more
Jan 30, 2023

Advanced Malignant Solid Tumor, Recurrent Ependymal Tumor, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +35 more
  • Birmingham, Alabama
  • +108 more
Oct 19, 2022

Advanced Malignant Solid Tumor, Recurrent Childhood Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +118 more
Jan 27, 2023

Undifferentiated Embryonal Sarcoma of Liver: Evaluation of

Recruiting
  • Hepatic Sarcoma
    • Strasbourg, France
      Service Pédiatrie Onco-hématologie - Pédiatrie III - CHU de Stra
    Nov 28, 2022

    Adrenal Cortex Carcinoma, Alveolar Soft Part Sarcoma, CNS Tumor Trial in United States (Cabozantinib, Cabozantinib S-malate,

    Active, not recruiting
    • Adrenal Cortex Carcinoma
    • +39 more
    • Birmingham, Alabama
    • +142 more
    May 24, 2022

    Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial in Puerto

    Recruiting
    • Malignant Solid Neoplasm
    • +26 more
    • Birmingham, Alabama
    • +121 more
    Aug 24, 2022

    Advanced Malignant Solid Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor Trial

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +30 more
    • Larotrectinib Sulfate
    • Birmingham, Alabama
    • +123 more
    Aug 23, 2022

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +35 more
    • Birmingham, Alabama
    • +113 more
    Jun 28, 2022

    Brain Tumor, CNS Tumor, Childhood Germ Cell Tumor Trial in Australia, Canada, United States (sodium thiosulfate, examination)

    Completed
    • Brain Tumor
    • +8 more
    • sodium thiosulfate
    • examination
    • Birmingham, Alabama
    • +75 more
    Jul 1, 2021

    Primary Extra-cranial Solid Tumor, Recurrent or Refractory Glypican 3 (GPC3) Trial in New York, Cincinnati (Codrituzumab)

    Recruiting
    • Primary Extra-cranial Solid Tumor
    • Recurrent or Refractory Glypican 3 (GPC3)
    • Los Angeles, California
    • +2 more
    Oct 28, 2022

    Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States

    Recruiting
    • Malignant Solid Neoplasm
    • +40 more
    • Biospecimen Collection
    • +6 more
    • Birmingham, Alabama
    • +172 more
    Jan 27, 2023

    Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

    Recruiting
    • Hematopoietic and Lymphoid Cell Neoplasm
    • +37 more
    • Birmingham, Alabama
    • +171 more
    Aug 24, 2022

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +44 more
    • Biopsy
    • +23 more
    • Birmingham, Alabama
    • +166 more
    Feb 2, 2023

    CNS/Leptomeningeal Tumors Trial in New York (131I-omburtamab)

    Available
    • Central Nervous System/Leptomeningeal Neoplasms
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 15, 2022

    Pediatric Oncology Trial in Worldwide (Regorafenib (BAY73-4506), Vincristine (Cellcristin®), Irinotecan (Irinotecan Cell

    Active, not recruiting
    • Pediatric Oncology
    • Regorafenib (BAY73-4506)
    • +2 more
    • Lyon, France
    • +11 more
    Jan 16, 2023

    Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +32 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Birmingham, Alabama
    • +124 more
    Aug 24, 2022

    Perihilar Cholangiocarcinoma, Klatskin Tumor, Bile Duct Cancer Trial in Oslo (Liver transplant)

    Recruiting
    • Perihilar Cholangiocarcinoma
    • +2 more
    • Liver transplant
    • Oslo, Norway
      Oslo university hospital
    Aug 5, 2021

    Anesthesia, Pediatric Cancer, Pediatric Tumor Trial in Moscow (Sugammadex)

    Unknown status
    • Anesthesia
    • +5 more
    • Moscow, Russian Federation
      Dmitry Rogachev National Research Center of Pediatric Hematology
    Nov 1, 2018

    Lung Cancer Trial in Houston (Cisplatin, Amifostine)

    Active, not recruiting
    • Lung Cancer
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Jun 29, 2022

    Cancer and Hearing Loss Related in Children

    Completed
    • Cancer in Children
    • Hearing Loss
    • Genetic study
    • Genetic study MT-RN1
    • Paris, France
      Institut Curie
    Apr 30, 2021

    Refractory and/or Relapsed Metastatic Solid Tumors Trial in United States (Cyclophosphamide, Fludarabine, low dose total body

    Recruiting
    • Refractory and/or Relapsed Metastatic Solid Tumors
    • Saint Petersburg, Florida
    • +4 more
    Oct 29, 2021

    Cancer Trial in United States (Gemcitabine, Nab-paclitaxel)

    Recruiting
    • Cancer
    • Aurora, Colorado
    • +3 more
    Oct 28, 2021

    Collecting and Storing Tissue From Young Patients With Cancer

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +13 more
    • Cytology Specimen Collection Procedure
    • Laboratory Biomarker Analysis
    • Birmingham, Alabama
    • +68 more
    Aug 4, 2022

    Personalizing Immune Checkpoint Inhibitor Therapy

    Withdrawn
    • Lung Cancer Stage IV
    • Blood and tumor tissue analysis, Clinical response.
    • Silver Spring, Maryland
      Holy Cross Hospital
    Sep 22, 2020